par Van Cutsem, Eric;Peeters, Marc;Siena, Salvatore;Humblet, Yves;Hendlisz, Alain ;Neyns, Bart;Canon, Jean-Luc;Van Laethem, Jean-Luc ;Maurel, Joan;Richardson, Gary;Wolf, Michael;Amado, Rafael G
Référence Journal of clinical oncology, 25, 13, page (1658-1664)
Publication Publié, 2007-05
Référence Journal of clinical oncology, 25, 13, page (1658-1664)
Publication Publié, 2007-05
Article révisé par les pairs
Titre: |
|
Auteur: | Van Cutsem, Eric; Peeters, Marc; Siena, Salvatore; Humblet, Yves; Hendlisz, Alain; Neyns, Bart; Canon, Jean-Luc; Van Laethem, Jean-Luc; Maurel, Joan; Richardson, Gary; Wolf, Michael; Amado, Rafael G |
Informations sur la publication: | Journal of clinical oncology, 25, 13, page (1658-1664) |
Statut de publication: | Publié, 2007-05 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Aged |
Antibodies, Monoclonal -- adverse effects -- pharmacology -- therapeutic use | |
Antineoplastic Agents -- adverse effects -- pharmacology -- therapeutic use | |
Colorectal Neoplasms -- drug therapy -- nursing -- pathology | |
Disease-Free Survival | |
Female | |
Humans | |
Immunohistochemistry | |
Male | |
Middle Aged | |
Neoplasm Metastasis | |
Receptor, Epidermal Growth Factor -- antagonists & inhibitors -- metabolism | |
Note générale: | Clinical Trial, Phase III |
Journal Article | |
Multicenter Study | |
Randomized Controlled Trial | |
Research Support, Non-U.S. Gov't | |
Langue: | Anglais |
Identificateurs: | urn:issn:0732-183X |
info:doi/10.1200/JCO.2006.08.1620 | |
info:pii/25/13/1658 | |
info:pmid/17470858 |